An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety

ADHD affects over 5% of children worldwide. It is typically treated with stimulant medications, and methylphenidate (MPH) is the most commonly prescribed. This study investigated the effectiveness, on symptoms and impairment, and safety of Equasym XL(®), a combination of 30% immediate-release and 70...

Descripción completa

Detalles Bibliográficos
Autores principales: Döpfner, Manfred, Görtz-Dorten, Anja, Breuer, Dieter, Rothenberger, Aribert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180616/
https://www.ncbi.nlm.nih.gov/pubmed/21901417
http://dx.doi.org/10.1007/s00787-011-0202-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180616/
https://www.ncbi.nlm.nih.gov/pubmed/21901417
http://dx.doi.org/10.1007/s00787-011-0202-4

Ejemplares similares